FindTrial
Sign In

Small Macular Hole through medical management

A pilot Study on Medical Management of Small Macular Hole.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041066
Enrollment
60
Registered
2022-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H358- Other specified retinal disorders

Interventions

Intervention1: Medical management group: Started on Predfort QID, Dorzox TDS Nevanac BD for 1 month Control Intervention1: Observational Group: Lubricants for 1 months

Sponsors

L V Prasad Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Idiopathic macular hole 2.Size less than 400 microns- minimal basal diameter

Exclusion criteria

Exclusion criteria: 1.Steroid responder 2.Sulfa drug allergy 3.Corneal disease with contraindication to use of Steroids, NSAIDS, CAIs

Design outcomes

Primary

MeasureTime frame
Anatomical and functional outcomes in small macular holes between the two groupsTimepoint: 3 week and 6 weeks—

Secondary

MeasureTime frame
NONETimepoint: NONE—

Countries

India

Contacts

Public ContactDrMukesh jain

L V Prasad Eye Institute

mukeshbr7@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026